Four arene osmium complexes were prepared containing derivatives of ethacrynic acid, a potent inhibitor of glutathione S-transferases, either by direct coordination or via N-or P-donor ligands. The complexes were characterized by spectroscopic and analytical methods and, for Os(η 6 -pcymene)(acetylacetonato)(2-(2,3-dichloro-4-(2-ethylenebutanoyl)phenoxy) acetato) and Os(η 6 -pcymene)Cl 2 (2-(2-(2,3-dichloro-4-(2-methylenebutanoyl)phenoxy)acetoxy)ethyl nicotinato), by singlecrystal X-ray diffraction. The cytotoxicity of the complexes towards the human ovarian cancer cells and non-tumorous human embryonic kidney cells was investigated, and two of the complexes, for which ruthenium analogues are known, helped to delineate the influence of the metal ion. Inhibition studies of intracellular glutathione S-transferases (GSTs -detoxification enzymes implicated in drug resistance) indicate that the observed cytotoxicity of the complexes involves GST inhibition, as well as other targets following dissociation of the ethacrynic acid group from the osmium(II) ion.
3
It has previously been shown that ethacrynic acid, originally developed as an inhibitor of glutathione Stransferases (GSTs, a family of cytosolic detoxification enzymes associated with drug resistance), potentiates the cytotoxic effect of several chemotherapeutic agents, including cisplatin. 10 Consequently, in an attempt to overcome drug resistance, ethacrynic acid has been tethered to the ruthenium(II)-arene framework via two distinct synthetic approaches, i.e. the modification of the arene ligand 11 and the introduction via an appropriate monodentate ligand. In this respect, ethacrynic acid-functionalized imidazole, 12 pyridine and triphenylphosphine-type 13 All the ruthenium and platinum complexes modified with ethacrynic acid manifest increased ability to inactivate GSTs and induce apoptosis, even in cisplatin resistant cell lines. 15 To the best of our 6 at 172.5 ppm in the 13 C NMR spectrum, i.e. at comparable frequency than that in ethacrynic acid itself (172.8 ppm). The 1 H and 13 C NMR spectra of 2 -3 display the resonances due to the LP and LN ligands close in value to those observed for the same ligands coordinated in analogous ruthenium complexes. 13 As a consequence of the formal substitution of a chloride with PTA on going from the neutral complex 3 to the cationic 4, the resonances of some pyridyl nuclei undergo significant shift to higher frequency (∆δ C20-H = 0.27 ppm in the 1 H spectra; ∆δ C19 = 3.1 ppm, ∆δ C17 = 1.6 ppm and ∆δ C20 = 2.6 ppm in the 13 C spectra; see Chart 4). The 31 P NMR resonance in 2 (at −12.1 ppm) appears at lower frequency respect to the free ligand, LP (−4.9 ppm), 13 whereas the 31 P NMR resonance due to the PTA ligand in 4 (−77.4 ppm) resembles the values previously reported for related arene osmium(II)
complexes. 19 The expected structures of 1 -4 were further corroborated by mass spectrometry and
It should be noted that the ligands LP and LN in 2 and 3 are less prone to dissociation than that previously observed for the analogous ruthenium complexes. 13 Indeed, LP in 2 is substantially inert towards dissociation (5% released after 72 hours in dmso/water and 12% released after 72 hours in the chloride containing solution). Spectroscopic and conductivity studies indicate that only minor amounts of 3 and 4 remain unchanged in the dmso/water and dmso/water/NaCl solutions for 62-72 hours, and that the LN ligand and chloride ligand compete for the exchange with the solvent in both cases.
Interestingly, the dissociation of the LN ligand from 3 and to a greater extent from 4 is partially suppressed in the respective NaCl solutions. 
Intracellular GST inhibition
Due to the potential of 1 -4 to inhibit GSTs inside cells, residual intracellular GST activity after incubation with the complexes and the ligands at the respective IC 50 concentrations was determined by fluorescence spectroscopy in A2780 and A2780cisR cells (Figure 4 ). Incubation for 18 hours led to a modest decrease in GST activity in both A2780 and A2780cisR cells with all the compounds, 1 being the least effective GST inhibitor. This appears to be in accordance with the low cytotoxicity exhibited by 1, which is prone to quickly release the ethacrynato anion in aqueous conditions (see above).
In principle, both the EA-CO 2 H and EA-(C=O)O(CH 2 ) 2 OH fragments might be generated inside the cells following dissociation of LN and LP from 2 -4. 15, 26 The most pronounced effects on GST activity were observed for 2 (20% inhibition) and 4 (30% inhibition) in A2780 cells and to a lesser extent in A2780cisR cells, which indicates that the GSH/GST detoxification system in A2780cisR cells is more active, reflected by twofold higher IC 50 values, compared to A2780 cells (Table 3 ).
The ligand LN inhibits GST in A2780cisR cells slightly more than in A2780 cells, which might contribute to the comparable cytotoxicity in A2780 cells and A2780cisR cells, respectively ( Table 3 ).
The intracellular GST inhibition values of 2 -4 do not correlate directly with the IC 50 values (compare Table 3 and Figure 4 ), thus suggesting that the cytotoxicity of the compounds may only be partially attributed to GST inhibition. Indeed, these results are consistent with a previous mechanistic study on a bifunctional arene ruthenium(II)-ethacrynic acid compound, indicating that the EA-unit inhibits GSTs, releasing the organometallic fragment which leads to a surge of cell death. 
Conclusions
The first osmium complexes containing ethacrynic acid, a broad acting inhibitor of GSTs, have been synthesized and characterized. For two of the complexes, 2 and 3, ruthenium analogues are known, whereas 1 and 4 are unique in that no ruthenium congeners have been reported. Compounds 2 and 3 are, as expected, more stable than the ruthenium analogues, in dmso/water and dmso/water/NaCl solutions. To within experimental error, there is no significant trend indicating that complexes of one metal (Ru or Os) are substantially more cytotoxic than the analogues of the other one, as previously noted. 27 The complex with the most stable Os-EA ligand bond, i.e. 2, in which the ethacrynic acid entity is connected to the osmium(II) ion via a P-donor ligand, is not the most cytotoxic compound, indicating that dissociation of the bioactive EA group from the metal ion could be important in the mechanism of drug action. Indeed, the antiproliferative activity of 2 may be attributed predominantly to the ethacrynic acid-derived ligand, as their IC 50 values are similar. This could explain why there is not a direct correlation between cytotoxicity and inhibition of intracellular GSTs, as the data suggest that GSTs are relevant targets, but not exclusive targets. Finally, incorporation of the pta ligand in 3 to afford 4 does not improve the cytotoxicity or selectivity of the compounds, presumably due to the major role of the ethacrynic acid-derived ligand in the overall biological activity observed.
Experimental
OsCl 3 ·3H 2 O (54% purity approx.) was purchased from Heraeus, while the organic reactants were purchased from Acros Organics and were of the highest purity available. Solvents were purchased from given in Hz. Conductivity measurements were carried out using an Eutech Con 700 instrument (cell constant = 1.0 cm −1 ). 29 UV-vis spectra were recorded with an Ultraspec 2100 Pro spectrophotometer.
Attenuated total reflection infrared spectra (ATR-IR) of solid samples were recorded on a Perkin-Elmer
Spectrum 100 FT-IR spectrometer. C, H, and N analyses were carried out with a Perkin-Elmer 2400 CHNS/O analyzer. High-resolution electrospray mass spectra (HRMS) were acquired using a MicroTOF-Q hybrid quadrupole time-of-flight spectrometer (Bruker Daltonics, Bremen, Germany) . 2966w, 2936w, 2912w, 2876w, 1660m, 1644s, 1587m, 1575m, 1556m, 1518s, 1469m, 1434w, 1383m, 1358vs, 1343w, 1285m, 1270m, 1265s, 1244w, 1219w, 1197w, 1146w, 1120w, 1083w, 1060s, 1031w, 1006m, 962w, 938w, 925w, 891w, 864m, 823w, 803s, 785m, 757w, 729s, 684w, 659w, 633m, 610m 
Synthesis of Os(η
6 -p-cymene)(acetylacetonato)(2-(2,3-dichloro-4-(2-ethylenebutanoyl)phenoxy) acetato), 1 A solution of Os(η 6 -p-cymene)(κ(C)-acac)(κ(O,O')-acac) (
Synthesis of Os(η 6 -p-cymene)Cl(2-(2-(2,3-dichloro-4-(2-methylenebutanoyl)phenoxy)acetoxy) ethylnicotinato)(1,3,5-triaza-7-phosphaadamantane) tetrafluoroborato, 4
A stirred solution of Os(η 6 -p-cymene)Cl 2 (PTA) (0.100 g, 0.181 mmol) in CH 2 Cl 2 (6 mL) was treated Compound 1. Λ M (dmso/water 9:1) = 3.4 S·cm 2 ·mol -1 (t = 5 min); 5.3 S·cm 2 ·mol -1 (t = 50 min); 4.6 S·cm 2 ·mol -1 (t = 6 h); 5.3 S·cm 2 ·mol -1 (t = 24 h); 3.8 S·cm 2 ·mol -1 (t = 114 h). UV-Vis (dmso/water 9:1), 7, 168.4, 165.7, 155.5, 149.7, 134.8-134.5, 133.3, 133.0, 132.9, 131.1, 130.1, 128.6-128.4, 127.8, 112.1, 88.9, 81.3, 80.3, 66.0, 63.4, 63.2, 30.1, 23.3, 22.1, 17.5, 12. 7 ppm (t = 5 min -72 h). 31 P NMR (d6-dmso/D 2 O 9:1): δ = −12.8 ppm (t = 5 min -22 h); δ = −12.8 (major, 2a), 26.6 (ca. 6%, LP=O) ppm (t = 51 h -72 h [δ = 86.6, 83.8, 71.8, 51.3, 30.8, 22.2, 22.0, 18.6 
X-ray crystallography
Crystal data and collection details for 1 and 3·CH 2 Cl 2 ·½[1,4-C 6 H 4 (OH) 2 ] are reported in Table 4 . X-ray data were collected on Bruker Smart APEX CCD (3) deposit@ccdc.cam.ac.uk).
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